1例支气管扩张合并糖尿病、痛风患者的药学监护

曹琴; 李昱柳; 曹琴; 李昱柳

doi:10.3969/j.issn.1006-0111.2017.02.019

[1]	成人支气管扩张症诊治专家共识编写组.成人支气管扩张症诊治专家共识[J].中华结核和呼吸杂志, 2012,35(7):485-492.
[2]	李詝,李久荣,高金明.北京协和医院136例支气管扩张症住院患者临床特征分析[J].中国医学科学院学报,2014,36(1):61-67.
[3]	Wong C, Jayaram L, Karalus N, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE):a randomized, double-blind, placebo-controlled trial[J].Lancet,2012,380(9842):660-667.
[4]	Altenburg J, de Graaf CS, Stienstra Y, et al. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis:The BAT Randomized Controlled Trail[J]. JAMA,2013,309(12):1251-1259.
[5]	Anwar GA, Bourke SC, Afolabi G,et al. Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis[J]. Respir Med, 2008,102(10):1494-1496.
[6]	Li H, Liu DH, Chen LL, et al. Meta-analysis of the adverse effects of long-term azithromycin use in patients with chronic lung diseases[J].Antimicrob Agents Chemother,2014,58(1):511-517.
[7]	Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, et al. Azithromycin:Mechanisms of action and their relevance for clinical applications[J]. Pharmacol Ther, 2014,143(2):225-245.
[8]	周启蒙,杜冠华.治疗高尿酸血症相关药物研究进展[J].中国新药杂志,2016,25(18):2129-2135.